PODCAST: “Charge Capture” Medical Coding and Healthcare Costs

The Basis for Hospital Reimbursement and Sepsis Reimbursement

By Eric Bricker MD




Thank You

Subscribe to the Medical Executive-Post




One Response

  1. Medicare Claws Back Money for Amniotic Stem Cell Shots

    Medicare is clawing back money it paid doctors for dubious birth tissue injections — a move that likely could put some clinics out of business, an orthopedic surgeon told MedPage Today. In late February, seven U.S. regional Medicare Administrative Contractors (MACs) announced that they will seek to recover losses from claims going back more than 2 years, for shots that cost some $2,000 apiece. For clinics that injected patients in multiple joints with at least two doses per joint, that could total thousands of dollars per day.

    “Any claims processed and paid for dates of service on or after Dec. 6, 2019 will be adjusted and payment will be recouped,” stated the announcement from WPS Government Health Administrators, which covers the Midwest region. “Impacted providers will receive an overpayment demand letter identifying the amount of overpayment.” The notice applies to amniotic, placental, and umbilical cord injectables, which the WPS notice describes as “experimental exosome biologic products that have not proven to be safe and effective for any medical use.”

    Source: Ann Miller RN MHA via Kristina Fiore, Medpage Today [3/16/22]

    Liked by 1 person

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: